Prevenar

Pipeline

Status by Indication[3][1]

Competition

Competitive Landscape

InfluenzaAsthmaAcute Otitis MediaAtaxia-Telangiectasia

1053 competitors in Influenza

#DrugCompanyPhaseTrials

1

Prevenar

GSK

Approved

22

Fluzone

Sanofi

Preclinical

163

Crestor

AstraZeneca

Preclinical

14

Trexall

Alnylam Pharmaceuticals

Preclinical

15

Quadrivalent Influenza Vaccine

Sanofi

Preclinical

306

COMIRNATY

Pfizer

Preclinical

17

Focetria

CChiltern Pesquisa Clinica Ltda

Preclinical

18

Influenza A/H5N1

NNational Institute of Allergy and Infectious Diseases (NIAID)

Preclinical

149

PD-1/PD-L1 Inhibitors

CChuangzhen Chen

Preclinical

110

Flulaval

NNational Heart, Lung, and Blood Institute (NHLBI)

Preclinical

1Show 13 more competitors

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Timeline

Expected Milestones

Clinical

Trials by Indication[1]

Children4 trials

Assessment of Antibody Persistence in Children Previously Vaccinated With Pneumococcal Conjugate Vaccine

Completed·GSK·Phase 3·NCT00624819·524 enrolled

Pneumococcal Vaccine Booster Study in Healthy Children 11-18 Months Old Previously Primed With the Same Vaccines

Completed·GSK·Phase 3·NCT00463437·1,437 enrolled

Pneumococcal Vaccine Booster Study in Healthy Children 12-18 Mths Old Previously Primed With the Same Vaccines

Completed·GSK·Phase 3·NCT00547248·756 enrolled

Show 1 more trial

A Study of MVA85A in Healthy Children and Infants

Completed·UUniversity of Oxford·Phase 2·NCT00679159·168 enrolled

Immunogenicity4 trials

Safety and Immunogenicity Study of GlaxoSmithKline (GSK) Biologicals' 10-valent Pneumococcal Conjugate Vaccine

Completed·GSK·Phase 3·NCT00344318·806 enrolled

Safety and Immunogenicity Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine.

Completed·GSK·Phase 3·NCT00370396·1,200 enrolled

Immunogenicity, Safety and Lot to Lot Consistency of Novartis Meningococcal B Recombinant Vaccine When Administered With Routine Infant Vaccinations to Healthy Infants

Completed·Novartis·Phase 3·NCT00657709·3,630 enrolled

Show 1 more trial

Primary & Booster Study to Evaluate the Immunogenicity and Safety of Menitorix Vaccine in Preterm Infants

Completed·GSK·Phase 3·NCT00586612·313 enrolled

Vaccine3 trials

Co-administration of Pneumococcal Conjugate Vaccine With DTPa-IPV-Hib Versus Co-administration With DTPa-HBV-IPV/Hib

Completed·GSK·Phase 3·NCT00652951·780 enrolled

Study Evaluating Prevenar Vaccine in Healthy Infants

Completed·Pfizer·Phase 4·NCT00276107·200 enrolled

Study to Evaluate GSK Biologicals' GSK2197870A Vaccine Given as Primary Course in Infants

Completed·GSK·Phase 2·NCT00871338·284 enrolled

Influenza2 trials

Study to Evaluate Safety and Immunogenicity of GSK Biologicals' Pandemic Influenza (H1N1) Candidate Vaccine in Children

Terminated·GSK·Phase 2·NCT01003418·8 enrolled

Dose Ranging Study of Combined Haemophilus Influenzae Type B-Meningococcal Serogroups CY (Hib-MenCY-TT) Vaccine

Completed·GSK·Phase 2·NCT00127855·409 enrolled

Vaccination2 trials

Primary Vaccination Course in Children Receiving Pneumococcal Conjugate Vaccine GSK 1024850A or Prevenar™ and Hiberix™

Completed·GSK·Phase 3·NCT00680914·503 enrolled

Pneumococcal Vaccination of Otitis-prone Children

Completed·LLund University Hospital·N/A·NCT01263210·109 enrolled

9 more indications

Effectiveness1 trial

A Study To Assess The Safety And Effectiveness Of Prevenar In Chinese Children Who Have Not Previously Received A Vaccine Against Pneumococcal Bacteria

Completed·Pfizer·Phase 4·NCT01193582·505 enrolled

Asthma1 trial

Safety and Immunogenicity of Sequential Pneumococcal Immunization in Preschool Asthmatics

Completed·JJohann Wolfgang Goethe University Hospital·Phase 4·NCT00836641·70 enrolled

Treatment1 trial

Study Evaluating Treatment of Fever in Children Who Have Been Vaccinated With Prevenar and Infanrix Hexa

Completed·Pfizer·Phase 4·NCT00294294·300 enrolled

Ataxia-telangiectasia1 trial

Immunogenicity of Pneumococcal Vaccines in Ataxia-telangiectasia Patients

Unknown status·SSheba Medical Center··NCT01075438·20 enrolled

Vaccines1 trial

Hib-MenCY-TT Vaccine Study Compared to Licensed Hib and Meningococcal Serogroup C Conjugate Vaccines

Completed·GSK·Phase 2·NCT00134719·1,104 enrolled

Immune Response1 trial

Study Evaluating the Safety and Ability to Produce Immune Response of Prevenar and Meningitec Given at the Same Time

Completed·Pfizer·Phase 4·NCT00581035·712 enrolled

Drug1 trial

Prevenar (13v) Infant Drug Use Investigation

Completed·Pfizer··NCT02119104·1,087 enrolled

Acute otitis media1 trial

Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media

Completed·Pfizer··NCT00195611·3,293 enrolled

Unspecified2 trials

Study Investigating Administration of Prevenar for Post-Marketing Surveillance

Completed·Pfizer··NCT00195390·600 enrolled

A PHASE 3, RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLINDED TRIAL TO EVALUATE THE SAFETY, TOLERABILITY, AND IMMUNOGENICITY OF A MULTIVALENT GROUP B STREPTOCOCCUS VACCINE IN HEALTHY PREGNANT WOMEN AND THEIR INFANTS

Recruiting·Pfizer·Phase 3·NCT07160244·6,000 enrolled

Details

Drug Info

Related News